Antioxidant Protective Effect of Glibenclamide and Metformin in Combination with Honey in Pancreas of Streptozotocin-Induced Diabetic Rats by Erejuwa, Omotayo Owomofoyon et al.
Int. J. Mol. Sci. 2010, 11, 2056-2066; doi:10.3390/ijms11052056 
 
International Journal of 
Molecular Sciences 
ISSN 1422-0067 
www.mdpi.com/journal/ijms 
Article 
Antioxidant Protective Effect of Glibenclamide and Metformin 
in Combination with Honey in Pancreas of Streptozotocin-
Induced Diabetic Rats 
Omotayo Owomofoyon Erejuwa 
1,*, Siti Amrah Sulaiman 
1, Mohd Suhaimi Abdul Wahab 
1,  
Sirajudeen Kuttulebbai Nainamohammed Salam 
2, Md Salzihan Md Salleh 
3 and Sunil Gurtu 
4 
1  Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia,  
16150 Kubang Kerian, Kelantan, Malaysia; E-Mails: sbsamrah@kb.usm.my (S.A.S.); 
msuhaimi@kb.usm.my (M.S.A.W.) 
2  Department of Chemical Pathology, School of Medical Sciences, Universiti Sains Malaysia,  
16150 Kubang Kerian, Kelantan, Malaysia; E-Mail: sirajuden@kb.usm.my 
3  Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia,  
16150 Kubang Kerian, Kelantan, Malaysia; E-Mail: matledpb@yahoo.com 
4  School of Medicine and Health Sciences, Monash University Sunway Campus, Jalan Lagoon 
Selatan, 46150, Bandar Sunway, Selangor, Malaysia; E-Mail: sgurtu@gmail.com 
*  Author to whom correspondence should be addressed; E-Mail: erejuwa@gmail.com;  
Tel.: +609-7666-877; Fax: +609-7653-370. 
Received: 9 March 2010; in revised form: 24 April 2010 / Accepted: 26 April 2010 /  
Published: 5 May 2010 
 
Abstract: Hyperglycemia exerts toxic effects on the pancreatic -cells. This study 
investigated the hypothesis that the common antidiabetic drugs glibenclamide and 
metformin, in combination with tualang honey, offer additional protection for the pancreas 
of streptozotocin (STZ)-induced diabetic rats against oxidative stress and damage. Diabetes 
was induced in male Sprague Dawley rats by a single dose of STZ (60 mg/kg; ip). Diabetic 
rats had significantly elevated levels of lipid peroxidation (TBARS), up-regulated activities 
of superoxide dismutase (SOD) and glutathione peroxidase (GPx) while catalase (CAT) 
activity was significantly reduced. Glibenclamide and metformin produced no significant 
effects on TBARS and antioxidant enzymes except GPx in diabetic rats. In contrast, the 
combination of glibenclamide, metformin and honey significantly up-regulated CAT 
activity and down-regulated GPx activity while TBARS levels were significantly reduced. 
OPEN ACCESSInt. J. Mol. Sci. 2010, 11                 
 
 
2057
These findings suggest that tualang honey potentiates the effect of glibenclamide and 
metformin to protect diabetic rat pancreas against oxidative stress and damage. 
Keywords: diabetes mellitus; streptozotocin; oxidative stress; pancreas; tualang honey; 
glibenclamide; metformin 
 
1. Introduction  
Diabetes mellitus is associated with progressive metabolic derangement, worsening glycemic 
control and morphological changes in the kidney, retina, pancreas and other organs [1-3]. Oxidative 
stress is known to play a significant role in the induction of these processes [4,5]. High levels of 
oxidative stress with excessive generation of free radicals and depleted levels of free radical 
scavenging enzymes have been demonstrated in several studies, both in experimental animal models of 
diabetes and in human diabetic subjects [6-8]. In type 1 diabetes, reactive oxygen species (ROS) are 
involved in β-cell dysfunction initiated by autoimmune reactions and inflammatory cytokines [9]. In 
type 2 diabetes, ROS activate β cell apoptotic pathways, impair insulin synthesis and also contribute to 
insulin resistance [10,11]. While oral hypoglycemic agents may be effective for glycemic control, at 
least in the early stages of diabetes, they do not appear to be effective in entirely preventing the 
progression of ROS mediated organ damage [3,12,13].  
Tualang honey has previously been reported to attenuate free radical scavenging enzymes and 
reduce lipid peroxidation in kidneys of streptozotocin (STZ)-induced diabetic rats [14]. In this study, 
we examine the effect of the two most commonly prescribed antidiabetic drugs, glibenclamide and 
metformin, as well as tualang honey on oxidative stress in the pancreas of diabetic rats. 
2. Methods 
Thirty-six male Sprague-Dawley rats aged 10-12 weeks (250-300 g) from the Laboratory Animal 
Research Unit were used in this study. The rats were housed at 25 ± 2 °C under 12 hour cycles of dark 
and light and were allowed standard food and water ad libitum.  
The rats were fasted for 18 hours before induction of diabetes. Diabetes was induced by a single 
intraperitoneal injection of freshly prepared streptozotocin (60 mg/kg) dissolved in 0.1 M citrate buffer 
(pH 4.5). Another group of rats (control) were injected with the same volume of citrate buffer. 
Streptozotocin (STZ)-injected rats exhibited symptoms of diabetes mellitus such as polyuria, 
polydipsia, polyphagia, and weight loss after 48 hours post STZ administration. Two days after the 
injection of STZ, fasting blood glucose concentration was measured with an Accu-Chek glucometer 
(Roche, Germany) using blood samples from the tip of the tail. Animals with blood glucose 
concentrations ≥ 14 mmol/L were considered diabetic and used in this study. Subsequently, fasting 
blood glucose was measured weekly in each rat. The rats were divided into 4 groups of 6 rats each. 
Using oral gavage, once each morning the rats were treated with tualang honey (AgroMas®, 
Malaysia), glibenclamide and/or metformin for four weeks (see Table 1). At the end of 4 weeks, the Int. J. Mol. Sci. 2010, 11                 
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animals were sacrificed and pancreatic tissue excised and processed. The Universiti Sains Malaysia 
Animal Ethics Committee approved this study. 
Table 1. Rat treatment groups. 
Group Treatment 
1  (Normal) Distilled water (0.5 mL) 
2  (Normal) Tualang honey (1.0 g/kg/body weight) 
3  (Diabetic) Distilled water (0.5 mL) 
4  (Diabetic) Tualang honey (1.0 g/kg/body weight) 
5  (Diabetic) Glibenclamide (0.6 mg/kg/body weight) + metformin (100 mg/kg/body weight) 
6  (Diabetic) Glibenclamide (0.6 mg/kg/body weight) + metformin (100 mg/kg/body weight) 
 + tualang honey (1.0 g/kg/body weight) 
 
2.1. Processing and Preparation of Tissue 
The pancreata were rapidly excised, washed in ice-cold normal saline, blotted, frozen in liquid 
nitrogen, and stored at −80 °C until use. 10% (w/v) homogenation of pancreatic tissues were made in 
Tris-HCl (0.1M, pH 7.4) using an ice-chilled glass homogenizing vessel in a homogenizer fitted with 
Teflon pestle (Glas-Col, USA) at 900 rpm. The suspended mixture was centrifuged at 1000  g for 
10  min at 4 °C in a refrigerated centrifuge. The resulting supernatant was used for the assay of 
activities of antioxidant enzymes, malondialdehyde concentrations and total protein. 
2.2. Superoxide Dismutase (SOD) Assay 
Superoxide dismutase (SOD) activity was measured using assay kit (Cayman, MI, USA) according 
to manufacturer’s instructions. This kit utilizes a tetrazolium salt for the detection of superoxide 
radicals generated by xanthine oxidase and hypoxanthine. One unit of SOD was defined as the amount 
of enzyme needed to produce 50% dismutation of superoxide radical. The SOD assay measures all the 
three types of SOD (Cu/Zn, Mn, and FeSOD). 
2.3. Glutathione Peroxidase (GPx) Assay 
Glutathione peroxidase (GPx) activity was measured using assay kit (Cayman, MI, USA) according 
to manufacturer’s instructions. The measurement of GPx activity is based on the principle of a coupled 
reaction with glutathione reductase (GR). The oxidized glutathione (GSSG) formed after reduction of 
hydroperoxide by GPx is recycled to its reduced state by GR in the presence of NADPH. The 
oxidation of NADPH is accompanied by a decrease in absorbance at 340 nm. One unit of GPx was 
defined as the amount of enzyme that catalyzes the oxidation of 1 nmol of NADPH per minute   
at 25 C. 
2.4. Catalase (CAT) Assay 
CAT activity was assayed according to the method of Goth [15]. In brief, this assay involves the 
incubation of a test tube containing 0.5 mL of hydrogen peroxide and 0.1 mL of pancreatic Int. J. Mol. Sci. 2010, 11                 
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homogenate. After incubation in a water bath at 37 °C for 60 seconds, the reaction was terminated by 
adding 0.5 mL of ammonium molybdate solution. A yellow complex of ammonium molybdate and 
hydrogen peroxide was formed. The absorbance of this yellow color was measured at 405 nm using 
spectrophotometer. One unit of CAT was defined as the amount of enzyme that catalyzes the 
decomposition of 1 µmol of hydrogen peroxide per minute. 
2.5. Glutathione Reductase (GR) Assay 
Glutathione reductase (GR) activity was measured according to the procedure of Goldberg and 
Spooner using oxidized glutathione (GSSG) as a substrate [16]. Briefly, 1 mL of 2.728 Mm GSSG 
solution and 40 µL of pancreatic homogenate were incubated in a water bath at 37 °C. After incubation 
for 5 minutes, the reaction was initiated by addition of 200 µL of 1.054 mM NADPH solution. The 
decrease in absorbance was measured at 340 nm using spectrophotometer and recorded every 30 
seconds over a period of 5 minutes. GR activity was expressed as unit per mg protein based on molar 
extinction coefficient of 6.22  10³ L/mol/cm. One unit of GR was defined as the amount of enzyme 
that catalyzes the oxidation of 1 nmol of NADPH per minute.  
2.6. Glutathione-S-Transferase (GST) Assay 
Glutathione-S-transferase (GST) activity was assayed according to the method of Habig et al [17]. 
This procedure is based on the conjugation of glutathione (GSH) to 1-chloro-2,4-dinitrobenzene 
(CDNB) as a substrate. Briefly, 2 mL of 0.3 M potassium phosphate buffer (pH 6.35), 75 µL of 30mM 
CDNB solution, 725 µL of distilled water and 0.1 mL of pancreatic homogenate were pipetted into a 
test tube. The test tube was vortexed and incubated at 37 °C for 10 minutes. After incubation, the 
reaction was initiated by addition of 100 µL of 30 mM reduced glutathione solution. The decrease in 
absorbance was measured spectrophotometrically at 340 nm and recorded every 30 seconds for 
4 minutes. GST activity was calculated as unit per mg protein based on a molar extinction coefficient 
of 9.6  10³ L/mol/cm. One unit of GST was defined as the amount of enzyme that catalyzes the 
conjugation of 1 nmol of GSH-CDNB per minute. 
2.7. Lipid Peroxidation (LPO) Assay 
The extent of lipid peroxidation was determined as the concentration of thiobarbituric acid reactive 
substances (TBARS), according to the method of Ohkawa et al. [18]. Briefly, 100 µL of pancreatic 
homogenates or MDA standards were pipetted into test tubes containing 1.5 mL of 20% (w/v) glacial 
acetic acid (pH 3.5), 200 µL of 8.1% (w/v) sodium dodecyl sulphate (SDS), 1.5 mL of 0.8% (w/v) 
thiobarbituric acid (TBA) and 700 µL of distilled water. The test tubes were incubated at 95 °C for 
60 minutes with a marble on top of each test tube. After incubation, the test tubes were cooled and then 
centrifuged at 3000 × g for 10 minutes. The amount of malondialdehyde (MDA) formed was measured 
spectrophotometrically at 532 nm. 1,1,3,3-Tetraethoxypropane (TEP), a form of MDA, was used as 
standard in this assay. TBARS concentration was expressed as nmol of malondialdehyde (MDA)   
per mg protein. 
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2.8. Protein Assay 
Protein concentration was estimated using Bio-Rad protein assay kit based on the method of 
Bradford [19]. A standard curve was generated using bovine serum albumin as the standard. 
2.9. Statistical Analysis  
Statistical analysis was carried out using SPSS 12.0.1. The data were expressed as medians 
(interquartile range). Groups were compared by the Kruskal-Wallis H test followed by Mann-Whitney 
U test to identify significance of difference between two groups. P  < 0.05 was considered to be 
statistically significant while n = 6.  
3. Results  
3.1. Lipid Peroxidation 
Figure 1a depicts the concentrations of thiobarbituric acid reactive substances (TBARS) in normal 
and STZ-treated pancreas. The diabetic control rats showed significantly (p < 0.01) elevated levels of 
TBARS compared with normal control rats. The diabetic groups that received honey or a combination 
of glibenclamide, metformin and honey showed a significant (p < 0.05, group 4; p < 0.01, group 6, 
respectively) decrease in TBARS levels compared with the diabetic control group. On the contrary, 
administration of glibenclamide and metformin to diabetic rats did not produce any significant 
difference on TBARS levels compared with diabetic control rats (Figure 1a). Moreover, the diabetic 
rats that received a combination of glibenclamide, metformin and honey showed a significant   
(p < 0.01) decrease in TBARS levels compared with those administered glibenclamide and metformin. 
3.2. Antioxidant Enzymes 
The activities of glutathione reductase (GR) and glutathione-S-transferase (GST) in the pancreas of 
normal and STZ-treated rats did not change (results not shown). Superoxide dismutase (SOD) activity 
was significantly (p < 0.05) elevated in the diabetic control group (group 3) compared with normal 
control rats (group 1) (Figure 1b). The honey-treated diabetic rats (group 4) showed significantly   
(p < 0.05) reduced SOD activity, whereas neither glibenclamide and metformin nor their combination 
reduced SOD activity in diabetic rats. Catalase (CAT) activity in the pancreas was significantly   
(p < 0.05) reduced in the diabetic control group 3 compared with the group 1 control rats (Figure 1c). 
The diabetic rats that received glibenclamide and metformin showed reduced catalase activity similar 
to the diabetic control group. Administration of honey or a combination of glibenclamide, metformin 
and honey significantly (p < 0.05) up-regulated CAT activity towards the normal control group (Figure 
1c). The diabetic control rats exhibited up-regulated activity of glutathione peroxidase (GPx) compared 
to normal control rats. Administration of honey, glibenclamide and metformin or their combination to 
diabetic rats significantly (p < 0.05, groups 4 and 6; p < 0.01, group 5) reduced GPx activity (Figure 1d). 
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Figure 1. Effects of honey, glibenclamide and metformin as well as their combination on 
(a) concentrations of thiobarbituric acid reactive substances (TBARS), (b) activity of 
superoxide dismutase (SOD), (c) activity of catalase (CAT) and (d) activity of glutathione 
peroxidase (GPx) in pancreas of control and streptozotocin-induced diabetic rats. Group 1 
(Normal control); Group 2 (Normal + Honey); Group 3 (Diabetic control); Group 4 
(Diabetic + Honey); Group 5 (Diabetic + Glibenclamide + Metformin); Group 6 (Diabetic 
+ Glibenclamide + Metformin + Honey).  
**  
† 
* 
††, ## 
* 
†† 
* 
† 
† 
* 
**, † 
**,††  **,† 
(a) (b)
(c) (d)
* 
 
Each group consisted of five to seven animals. Data are expressed as median (interquartile range). 
Values are statistically significant at *p < 0.05, **p < 0.01 compared with group 1; †p < 0.05, 
††p < 0.01 compared with group 3 and ## p< 0.01 compared with group 5.  
One unit of SOD was defined as the amount of enzyme needed to exhibit 50% dismutation of 
superoxide radical.  
One unit of CAT was defined as the amount of enzyme that catalyzes the decomposition of 1 μmol 
of H2O2 per minute.  
One unit of GPx was defined as the amount of enzyme that catalyzes the oxidation of 1 nmol of 
NADPH per minute. 
 
3.3. Blood Glucose 
Figure 2a shows the levels of blood glucose at the end of the experimental period. Before treatment 
commenced, the diabetic control rats (group 3) and diabetic-treated groups (groups 4, 5 and 6) had 
comparable levels of blood glucose (results not shown). The diabetic rats had significantly (p < 0.01) 
elevated blood glucose concentrations compared with non-diabetic rats. After four weeks of treatment, Int. J. Mol. Sci. 2010, 11                 
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all the diabetic rats that received honey, glibenclamide and metformin or their combination had 
significantly (p < 0.05, group 4; p < 0.01, groups 5 and 6) reduced blood glucose concentrations 
compared with diabetic control rats (Figure 2a).  
3.4. Body Weight 
Figure 2b shows the change in body weight at the end of the experimental period. Before the 
commencement of this study, all the groups had similar body weight (data not shown). The body 
weight was significantly (p < 0.01) reduced in STZ-treated rats compared with normal control rats 
(group 1). The glibenclamide and metformin treated diabetic rats did not show significant weight gain. 
However, the diabetic groups that received honey or glibenclamide and metformin in combination with 
honey exhibited significant (p < 0.01, group 4; p < 0.05, group 6) improvement in weight gain 
compared with diabetic control rats (Figure 2b). 
Figure 2. Effects of honey, glibenclamide and metformin as well as their combination on 
(a) blood glucose concentrations and (b) change in body weight of control and 
streptozotocin-induced diabetic rats. Each group consisted of five to seven animals. Group 
1 (Normal control); Group 2 (Normal + Honey); Group 3 (Diabetic control); Group 4 
(Diabetic + Honey); Group 5 (Diabetic + Glibenciamide + Metformin); Group 6 (Diabetic 
+ Glibenciamide + Metformin + Honey).  
**
**
**, † 
** 
**,†† 
††  
**,† 
** **
**,†  
††  
*,††  
(a) (b)
 
Data are expressed as median (interquartile range).  
Values are statistically significant at * p < 0.05, ** p < 0.01 compared with group 1 and 
†p < 0.05, ††p < 0.01 compared with group 3.  
Change in body weight is the difference between initial body weight before treatment and final 
body weight at the end of the treatment period. 
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4. Discussion 
The role of oxidative stress in the pathogenesis and complications of diabetes mellitus is well 
recognized [4-5,11]. Both human and experimental animal models of diabetes exhibit high oxidative 
stress due to persistent and chronic hyperglycemia, which depletes the activity of free radical 
scavenging enzymes and thus promotes free radicals generation [6-8]. Oxidative stress has lately been 
reported to be responsible, to a certain extent, for the β-cell dysfunction caused by glucose   
toxicity [20].  
The pancreatic -cells are highly prone to oxidative stress and damage because they have low 
expression and activity of antioxidant enzymes, which are the first line of defense against oxidative 
insult [21]. In this study, we found that the activity of superoxide dismutase (SOD) was up-regulated in 
the diabetic pancreas. SOD catalyzes the dismutation of superoxide (O2
•−) radical to hydrogen peroxide 
(H2O2) [22]. Although SOD is an antioxidant enzyme, some studies have suggested that its over-
expression is actually harmful to cells [23]. The toxic effect of ROS observed in many cells with over-
expressed SOD has been linked to elevated levels of H2O2 and accompanying oxidative damage 
following hydroxyl radical formation [24]. The implication for SOD up-regulation is that there would 
be high turnover of H2O2. Since CAT, which inactivates H2O2 is an endogenous enzyme and needs to 
be replenished; the continuous formation of H2O2 might overwhelm this enzyme. Moreover, O2
•− is 
reported to inhibit CAT directly [25] so the ROS could have caused its reduced activity in the   
diabetic rats.  
Glutathione peroxidase (GPx) is reported to have a broader protective spectrum than CAT because 
in addition to H2O2, it also metabolizes other hydroperoxides including lipid hydroperoxides [26]. The 
accumulation of H2O2 and other hydroperoxides might have induced the activity of GPx leading to its 
up-regulation in the diabetic rats. The observation that rodent and human islets have reduced 
expression of GPx has led to the conclusion that a normal approach for protection of -cells against 
oxidative stress would involve over-expression of GPx [27]. Thus, the over-expression of GPx could 
be a protective mechanism against oxidative stress. Administration of honey up-regulated CAT activity 
and down-regulated the activity of SOD and GPx, thus indicating that honey attenuated the changes in 
the pancreatic antioxidant enzymes in response to generation of oxidants. On the other hand, 
glibenclamide and metformin down-regulated activity of GPx but did not produce any effect on CAT 
activity. However, the diabetic rats that received glibenclamide and metformin in combination with 
honey showed over-expressed CAT activity and also down-regulated activity of GPx indicating that 
glibenclamide and metformin in combination with tualang honey provide better attenuation of 
antioxidant enzymes. 
Lipid peroxidation of unsaturated fatty acids is a frequently used indicator of increased oxidative 
stress and subsequent oxidative damage [28]. The enhanced activity of SOD and reduced CAT activity 
might generate excessive H2O2, which could give rise to other ROS such as hydroxyl radicals [23,24]. 
Lipid peroxidation impairs cell membrane fluidity and alters the activity of membrane-bound enzymes 
and receptors resulting in membrane malfunction [29]. The high level of lipid peroxidation marker, 
TBARS, in the diabetic control rats is a reflection of insufficiency of antioxidant defenses in 
combating ROS-mediated damage. This further shows that the up-regulation of SOD and GPx Int. J. Mol. Sci. 2010, 11                 
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activities in the diabetic rats was an adaptive/defense mechanism but not protective against oxidative 
stress. The diabetic rats that received glibenclamide and metformin alone had significantly higher 
levels of TBARS than those that received glibenclamide and metformin in combination with tualang 
honey. This seems to suggest that glibenclamide and metformin does not offer protection against lipid 
peroxidative damage in pancreas. Therefore, this implies that honey offers additional antioxidant effect 
to glibenclamide and metformin, thereby protecting the pancreas from oxidative stress-induced 
damage. 
In STZ-induced diabetic rats, diabetes develops as a result of irreversible pancreatic -cell 
destruction leading to degranulation and reduced insulin secretion [30]. STZ-induced diabetes was 
characterized by a severe loss in body weight, which has also been reported by other researchers [31]. 
The decrease in body weight in diabetic rats may indicate loss or degradation of structural proteins, 
which have been reported to contribute to body weight [32]. The present study showed that 
glibenclamide and metformin did not prevent weight loss. However, administration of honey alone or 
in combination with glibenclamide and metformin significantly improved body weight. Since 
glibenclamide and metformin, despite their hypoglycemic effect, did not have any effect on body 
weight, this shows that improvement of body weight by tualang honey is probably not related to its 
hypoglycemic effect but perhaps, it is acting through other mechanism(s). 
5. Conclusions 
This study shows that oxidative stress is still evident in the pancreas of diabetic rats administered 
the two most commonly prescribed antidiabetic drugs, glibenclamide and metformin. The 
administration of these two drugs in combination with tualang honey inhibited lipid peroxidation and 
attenuated the altered activities of antioxidant enzymes. In other words, based on our data, it can be 
said that tualang honey provides additional antioxidant effect to glibenclamide and metformin. Thus, 
the additional antioxidant protection exhibited by a combination of glibenclamide, metformin and 
tualang honey can be ascribed to tualang honey. This protection on pancreas against oxidative stress 
might also partially have contributed to the hypoglycemic effect of tualang honey in diabetic rats. This 
study establishes a basis for the need of antioxidant therapy in combination with hypoglycemic drugs 
in the management of diabetes mellitus. 
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